Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits
Written By : Dr. Pramila Kalra
Written By : Dr Jamshed J. Dalal
Published On 2025-04-08 07:04 GMT | Update On 2025-04-08 08:54 GMT
Advertisement
In the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond Glycemic Benefits. We are excited to bring you Episode 3 of the Right Turn Show, featuring two eminent experts in their respective fields: Dr Jamshed J. Dalal – Interventional Cardiologist & Honorary Director of Cardiac Sciences, Kokilaben Dhirubhai Ambani Hospital, Mumbai. Dr Pramila Kalra is a Renowned Endocrinologist, Professor, & Head of Endocrinology, Ramaiah Medical College & Hospital, Bangalore.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.